CAR-T Therapy – Respond or not to Respond

CAR-T therapy is making great advances in the oncology market but there are still questions to be answered on the variability of responders. This article gives some insight into the variability of this novel treatment.

http://www.philly.com/philly/health/penn-study-points-to-why-t-cell-therapy-fails-in-some-patients-20180430.html?__vfz=medium%3Dsharebar 

 

On 01-05-2018 0 1356

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

×

Make an appointment and we’ll contact you.